In this review, we will discuss the immunological basis for psoriasis with special emphasis on the role of effector T cells. With the understanding of this immunologic process, we will present a model for the development of targeted immune response modifiers, termed biologic immunotherapies, and their potential role for the benefit of patients with psoriasis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0190-9622(03)01134-4 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!